Literature DB >> 10469216

Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins.

N J Trendell-Smith1, D Peston, S Shousha.   

Abstract

AIM: Adenoid cystic carcinoma (ACC) of the breast is an uncommon well-differentiated tumour with good prognosis, and sometimes difficult to distinguish from in-situ and invasive cribriform carcinoma (ICC) which are relatively more common. Recently, we encountered a case of ACC that proved to be totally oestrogen receptor (ER) negative by immunohistochemistry. We investigated the possibility that this may be a consistent feature that can help in differentiating ACC from ICC which are usually ER positive. METHODS AND
RESULTS: The immunoperoxidase technique was used to study the expression of ER and other related proteins in six cases of ACC and two cases of ICC. All ACC cases were negative for oestrogen (ER) and progesterone (PgR) receptors whereas the two ICC were strongly positive for ER and showed a variable degree of PgR positivity. In addition, ACC cases were pS2 negative and showed minimal expression of prolactin receptors (PrlR), while the two ICC showed widespread and strong staining for pS2 and PrlR. The percentages of cells staining positively for Ki67 and p27 were generally lower in ACC than in ICC. Both tumour types were c-erbB-2 negative, but p53 was weakly to moderately positive.
CONCLUSIONS: The findings suggest that a negative immunoperoxidase staining for ER would confirm the diagnosis of ACC in contrast to the positive staining which is always seen in ICC. The findings also raise the issue of the presence of a specific class of ER negative breast carcinomas which are negative not because of poor differentiation, but because of their derivation from, or differentiation along, an ER negative cell lineage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469216     DOI: 10.1046/j.1365-2559.1999.00722.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Estrogen and progesterone receptor and p53 gene expression in adenoid cystic cancer.

Authors:  Jose E Barrera; Kenneth R Shroyer; Sherif Said; George Hoernig; Raymond Melrose; Paul D Freedman; Tanya A Wright; Robert O Greer
Journal:  Head Neck Pathol       Date:  2007-10-26

Review 2.  Adenoid cystic carcinoma of breast: Recent advances.

Authors:  Kosuke Miyai; Mary R Schwartz; Mukul K Divatia; Rose C Anton; Yong Wook Park; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

3.  Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.

Authors:  Bassam Ghabach; William F Anderson; Rochelle E Curtis; Mark M Huycke; Jackie A Lavigne; Graça M Dores
Journal:  Breast Cancer Res       Date:  2010-07-23       Impact factor: 6.466

Review 4.  Malignant adenomyoepithelioma combined with adenoid cystic carcinoma of the breast: a case report and literature review.

Authors:  Ying Yang; Yanmei Wang; Jinsong He; Guoqing Pan; Xiaoyu Tuo; Aimei Jiang; Li Bian
Journal:  Diagn Pathol       Date:  2014-07-23       Impact factor: 2.644

5.  Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis.

Authors:  Silvia Mihaela Ilie; Xenia Elena Bacinschi; Inga Botnariuc; Rodica Maricela Anghel
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-11-23

6.  Collagenous spherulosis in an adenomyoepithelioma of the breast.

Authors:  J S Reis-Filho; L G Fulford; B Crebassa; S Carpentier; S R Lakhani
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

7.  Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.

Authors:  Luigi Strizzi; Katharine M Hardy; Naira V Margaryan; David W Hillman; Elisabeth A Seftor; Beiyun Chen; Xochiquetzal J Geiger; E Aubrey Thompson; Wilma L Lingle; Cathy A Andorfer; Edith A Perez; Mary J C Hendrix
Journal:  Breast Cancer Res       Date:  2012-05-11       Impact factor: 6.466

8.  Overexpression of MACC1 and Its significance in human Breast Cancer Progression.

Authors:  Yongbo Huang; Huizhong Zhang; Junchao Cai; Lishan Fang; Jueheng Wu; Caisheng Ye; Xun Zhu; Mengfeng Li
Journal:  Cell Biosci       Date:  2013-03-18       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.